Trial Profile
Cilostazol After Lower Extremity Arterial Revascularization Trial (CLEAR)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2018
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary)
- Indications Peripheral arterial disorders
- Focus Therapeutic Use
- Acronyms CLEAR
- 21 Nov 2018 Status changed from to discontinued.
- 20 Oct 2017 Status changed from active, no longer recruiting to completed.
- 01 Jun 2017 Planned End Date changed from 1 Oct 2017 to 1 Aug 2017.